← Open Payments lookup

KATRINA CHAMBERS: Open Payments

NPI 1710695143 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,784 in 189 payments from 21 companies in 2025. Trend: 2023 $1,502 · 2024 $3,927 · 2025 $4,784

Food & beverage: $4,700Education: $84
CompanyPaymentsAmount
ABBVIE INC.39$1,083
Janssen Biotech, Inc.31$720
GENZYME CORPORATION11$490
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$466
Takeda Pharmaceuticals U.S.A., Inc.8$281
Madrigal Pharmaceuticals14$245
Celltrion USA Inc.10$211
Lilly USA, LLC7$209
QOL Medical, LLC12$193
Aimmune Therapeutics, Inc.7$147

Products named: TREMFYA, DUPIXENT, XIFAXAN, SKYRIZI, RINVOQ, ENTYVIO, REZDIFFRA, VEGZELMA.

Industry payments across CA — which companies pay providers there.